Gilead CEO, President Trump, FDA head on authorization for Remdesivir

Gilead CEO Daniel O'Day, President Trump, FDA Commissioner Stephen Hahn and Dr. Deborah Birx discuss the FDA's emergency authorization to use Remdesivir in treating Covid-19 patients.